17.03.2018 • NewsBiotechnologyCRBDavid Estapé

David Estapé to Join CRB Group as Technology Manager Biotechnology

David Estapé will join CRB Group from M+W Group as Technology Manager...
David Estapé will join CRB Group from M+W Group as Technology Manager Biotechnology

David Estapé, a long-time biotechnology expert who holds a doctorate in chemical engineering and has 22 years of experience, will join CRB Group as  Technology Manager Biotechnology and will be based in Basel, Switzerland.

Currently Technology Manager Life Sciences at M+W Group, an international plant engineering firm, Estapé has worked on major biotech projects globally, driven biotech strategy internally, gained experience in GMP and facility design for biopharma, and participated heavily in organizations like the International Society for Pharmaceutical Engineering (ISPE), BioPhorum Operations Group and Parenteral Drug Association. 

Estapé studied Chemical Engineering at the Autonomous University of Barcelona (UAB) and received his degree in 1989. After an Erasmus exchange study at the Technical University Delft (NL) he did his PhD research at the GBF (Gesellschaft für Biotechnologische Forschung) in Braunschweig, Germany. In 1996 he received his PhD degree from the UAB and joined Life Sciences Meissner + Wurst (LSMW), a German life sciences solutions provider that later became part of M+W Group. Starting as junior engineer, in his 22-year career at M+W Estapé held various positions and eventually became Technology Manager in the global business unit Life Sciences and Chemicals.

Estapé’s major focus at CRB will be to provide CRB’s clients with expertise in biotechnology front-end engineering, process technologies, regulatory/Good Manufacturing Practice, advanced facility design and strategic planning. While he will be based in Basel, Estapé will be available to support all 15 of CRB’s offices and enhance CRB’s existing capabilities in the biotechnology market.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.